Epstein–Barr Virus-Positive Primary CNS Lymphoma in a Patient Receiving Mycophenolate Mofetil: Diagnostic and Therapeutic Considerations
Viruses · 22.04.2026 · 18 (5) · 485
DOI: 10.3390/v18050485 ↗Kurz gefasst
Fallbericht in der Zeitschrift Viruses, online erschienen am 22.04.2026. Verfasst von Danielle N Burner und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, USA. Hauptthemen laut MEDLINE: Mycophenolic Acid, Epstein-Barr Virus Infections, Herpesvirus 4, Human, Central Nervous System Neoplasms. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Epstein–Barr virus (EBV)-positive primary central nervous system lymphoma (PCNSL) is a rare entity typically associated with profound immunosuppression, most commonly in transplant recipients or individuals with HIV. We report a case of EBV-positive PCNSL arising in a 75-year-old male with myasthenia gravis receiving chronic mycophenolate mofetil (MMF) therapy outside the transplant setting. The patient presented with progressive neurological deficits, and brain magnetic resonance imaging demonstrated multiple enhancing lesions. Stereotactic biopsy revealed diffuse large B-cell lymphoma of non–germinal center subtype with immunoblastic features and EBV-encoded RNA (EBER) positivity, confirming EBV-positive PCNSL. MMF was discontinued, and the patient was treated with rituximab and high-dose methotrexate, resulting in stable disease. This case highlights that prolonged MMF therapy may confer sufficient immunosuppression to permit EBV-driven lymphoproliferative disease even in non-transplant patients. Early recognition, withdrawal of immunosuppression, and initiation of methotrexate-based chemotherapy can lead to favorable outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, USA.
- Department of Pathology, Duke University School of Medicine, Durham, NC 27710, USA.
- Department of Neurosurgery, Duke University School of Medicine, Durham, NC 27710, USA.
- Cancer and Stem Cell Biology, Duke-NUS Medical School, 8 College Road, Singapore 169857, Singapore.
ORCID-Profile: Danielle N Burner, Giselle Y López, Micah A Luftig
Förderung
- NCI NIH HHS
- National Cancer Institute
Zitieren
APA
Burner, D. N., López, G. Y., Low, J. T., & Luftig, M. A. (2026). Epstein–Barr Virus-Positive Primary CNS Lymphoma in a Patient Receiving Mycophenolate Mofetil: Diagnostic and Therapeutic Considerations. Viruses, 18(5), 485. https://doi.org/10.3390/v18050485
Vancouver
Burner DN, López GY, Low JT, Luftig MA. Epstein–Barr Virus-Positive Primary CNS Lymphoma in a Patient Receiving Mycophenolate Mofetil: Diagnostic and Therapeutic Considerations. Viruses. 2026;18(5):485. doi:10.3390/v18050485
BibTeX
@article{Burner2026,
author = {Burner, Danielle N and López, Giselle Y and Low, Justin T and Luftig, Micah A},
title = {Epstein–Barr Virus-Positive Primary CNS Lymphoma in a Patient Receiving Mycophenolate Mofetil: Diagnostic and Therapeutic Considerations},
journal = {Viruses},
year = {2026},
volume = {18},
number = {5},
pages = {485},
doi = {10.3390/v18050485}
}
EUVIMED